In vitro evaluation of Rheum ribes extract on periodontal cells: cellular proliferation, biomarker modulation, and bioactivity assessment

Abstract Background This study aimed to evaluate the effects of Rheum ribes (R. ribes) extract on human periodontal ligament fibroblasts (hPDLF), human gingival fibroblasts (hGF), and human osteoblasts (hOB), to assess its bioactivity profile and explore its possible association with the Wnt/β-catenin signalling pathway. To the best of our knowledge, this is the first in vitro study evaluating R. ribes for periodontal applications. Methods The phenolic profile and bioactivity of the R. ribes extract were assessed using HPLC–DAD, FCR, DPPH, CUPRAC, FRAP, AChE inhibition and antimicrobial assays. The effects of R. ribes extract (2.5, 5, and 25 µg/mL) on cell viability were assessed using the MTT assay. The optimal dose (2.5 µg/mL) was further analysed by ELISA to measure levels of collagen type​-​​1 (Col-1), bone morphogenetic protein-2 (Bmp-2), axis inhibition protein-2 (Axin-2), and fibroblast growth factor-2 (Fgf-2). Results Syringic acid and quinic acid were identified using HPLC–DAD analysis. R. ribes extract exhibited higher copper(II) ion-reducing activity, but lower iron(III)-reducing activity, free radical scavenging capacity, and AChE inhibitory activity compared to the reference standards. Antimicrobial activity was detected against Staphylococcus epidermidis, Proteus mirabilis, and Candida albicans. In the MTT assay, 2.5 µg/mL significantly increased cell viability, whereas 25 µg/mL exhibited cytotoxic effects across all cell types. ELISA revealed significant increases in Col-1, Bmp-2, and Axin-2 levels in hPDLF and hOB cells treated with 2.5 µg/mL extract, while Fgf-2 levels significantly decreased in hOB cells ( p < 0.001). Conclusions R. ribes extract may support periodontal wound healing by enhancing cell viability and modulating key biomarkers. Further experimental and clinical assessments are necessary to corroborate these outcomes and clarify the extract's therapeutic potential.

Authors

Institutions

Publication Details

Journal
BMC Complementary Medicine and Therapies
Published
2026-11-14
DOI
https://doi.org/10.1186/s12906-026-05681-z
Primary Topic
Oral microbiology and periodontitis research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

In vitro evaluation of Rheum ribes extract on periodontal cells: cellular proliferation, biomarker modulation, and bioactivity assessment

Erkan Rayaman, Duygu Taşkın, Turgut Taşkın, Ömer Birkan Ağralı et al.
4 links
BMC Complementary Medicine and Therapies
Oral microbiology and periodontitis research
article

In vitro evaluation of Rheum ribes extract on periodontal cells: cellular proliferation, biomarker modulation, and bioactivity assessment

Erkan Rayaman, Duygu Taşkın, Turgut Taşkın, Ömer Birkan Ağralı, Dilruba Baykara, Ayşegül Tiryaki, Sema Tuğçe Aydın, Aleyna Yakut, Umut Ulaş Tosun, Canan Ekinci Doğan, Oğuzhan Gündüz
article en

Abstract

Abstract Background This study aimed to evaluate the effects of Rheum ribes (R. ribes) extract on human periodontal ligament fibroblasts (hPDLF), human gingival fibroblasts (hGF), and human osteoblasts (hOB), to assess its bioactivity profile and explore its possible association with the Wnt/β-catenin signalling pathway. To the best of our knowledge, this is the first in vitro study evaluating R. ribes for periodontal applications. Methods The phenolic profile and bioactivity of the R. ribes extract were assessed using HPLC–DAD, FCR, DPPH, CUPRAC, FRAP, AChE inhibition and antimicrobial assays. The effects of R. ribes extract (2.5, 5, and 25 µg/mL) on cell viability were assessed using the MTT assay. The optimal dose (2.5 µg/mL) was further analysed by ELISA to measure levels of collagen type​-​​1 (Col-1), bone morphogenetic protein-2 (Bmp-2), axis inhibition protein-2 (Axin-2), and fibroblast growth factor-2 (Fgf-2). Results Syringic acid and quinic acid were identified using HPLC–DAD analysis. R. ribes extract exhibited higher copper(II) ion-reducing activity, but lower iron(III)-reducing activity, free radical scavenging capacity, and AChE inhibitory activity compared to the reference standards. Antimicrobial activity was detected against Staphylococcus epidermidis, Proteus mirabilis, and Candida albicans. In the MTT assay, 2.5 µg/mL significantly increased cell viability, whereas 25 µg/mL exhibited cytotoxic effects across all cell types. ELISA revealed significant increases in Col-1, Bmp-2, and Axin-2 levels in hPDLF and hOB cells treated with 2.5 µg/mL extract, while Fgf-2 levels significantly decreased in hOB cells ( p < 0.001). Conclusions R. ribes extract may support periodontal wound healing by enhancing cell viability and modulating key biomarkers. Further experimental and clinical assessments are necessary to corroborate these outcomes and clarify the extract's therapeutic potential.

BMC Complementary Medicine and Therapies
Sağlık Bilimleri Üniversitesi (TR), Marmara University (TR)
Marmara Üniversitesi
Good health and well-being
Oral microbiology and periodontitis research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon